Related Experiment Video
Updated: Aug 9, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
The Tre2 oncoprotein, implicated in Ewing's sarcoma, interacts with two components of the cytoskeleton
Christophe Dechamps1, Stephane Bach, Daniel Portetelle
1Animal and Microbial Biology Unit, Gembloux Agricultural University, Avenue Maréchal Juin 6, Gembloux, B-5030, Belgium.
Abstract:
The product of the Tre2 oncogene, structurally related to the Ypt/RabGTPase-activating proteins (Ypt/RabGAP), is involved in various human cancers, including Ewing's sarcoma. In order to identify proteins interacting with the GAP part of this protein, we performed yeast two-hybrid screening of two libraries. Two components of the cytoskeleton were thus identified, whose interaction with the GAP region was confirmed by GST-pulldown, co-immunoprecipitation, and colocalisation experiments. The proteins found to interact with the GAP region are the light regulatory chain of myosin II (Myl2) and LOC91256, a protein containing ankyrin repeats.
Insights
The Tre2 oncogene protein interacts with cytoskeletal components, specifically myosin II regulatory light chain (Myl2) and LOC91256. This discovery sheds light on cancer-related protein interactions.
Area of Science:
- Molecular biology
- Oncology
- Cell biology
Background:
- The Tre2 oncogene product, a Ypt/RabGTPase-activating protein (Ypt/RabGAP), is implicated in human cancers like Ewing's sarcoma.
- Understanding protein interactions is crucial for deciphering cancer mechanisms.
Purpose of the Study:
- To identify proteins that interact with the GTPase-activating protein (GAP) domain of the Tre2 oncogene product.
- To elucidate potential roles of these interactions in cancer biology.
Main Methods:
- Yeast two-hybrid screening using two libraries.
- GST-pulldown assays.
- Co-immunoprecipitation.
- Colocalization experiments.
Main Results:
- Identified two cytoskeletal proteins interacting with the GAP region of the Tre2 oncogene product.
- Confirmed interactions with the light regulatory chain of myosin II (Myl2).
- Confirmed interactions with LOC91256, a protein containing ankyrin repeats.
Conclusions:
- The Tre2 oncogene product interacts with key cytoskeletal proteins Myl2 and LOC91256.
- These interactions may play a role in the oncogenic functions of Tre2.
- Further research into these interactions could reveal novel therapeutic targets for cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Cytoskeletal Accessory Proteins
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

